GLIDAPAFLOZIN M 10/500

Description

Dapagliflozin and Metformin Hydrochloride Extended-Release What is GLIDAPAFLOZIN M 10/500? GLIDAPAFLOZIN M 10/500 is a powerful oral antidiabetic medicine that combines two effective agents: Dapagliflozin (10 mg): Belongs to the class of SGLT2 inhibitors. It lowers blood sugar by helping the kidneys remove excess glucose through urine. Metformin Hydrochloride Extended-Release (500 mg): A biguanide that reduces glucose production in the liver and improves the body’s sensitivity to insulin. This dual-action formulation helps in achieving better glycemic control in patients with Type 2 Diabetes Mellitus (T2DM), especially when diet, exercise, and single-drug therapy are not enough. Uses of Dapagliflozin and Metformin Hydrochloride Extended-Release GLIDAPAFLOZIN M 10/500 is used for: Management of Type 2 Diabetes Mellitus Improving blood sugar control in adults with uncontrolled diabetes Reducing risk of diabetes-related complications like nerve damage, kidney problems, and eye damage Supporting weight management in diabetic patients by reducing glucose reabsorption Helping lower the risk of cardiovascular events in diabetic patients with heart conditions Side Effects of GLIDAPAFLOZIN M 10/500 Like any medication, GLIDAPAFLOZIN M 10/500 may cause side effects in some patients. Common ones include: Urinary tract infections (UTIs) Increased urination Thirst or dehydration Headache or dizziness Stomach upset, diarrhea, or nausea (mainly due to metformin) Genital fungal infections Rare but serious side effects may include lactic acidosis (due to metformin) and ketoacidosis (due to dapagliflozin). Patients should seek medical attention immediately if they experience severe weakness, confusion, breathing difficulty, or abdominal pain. Precautions Before Using Patients should take certain precautions before starting GLIDAPAFLOZIN M 10/500: Not recommended for Type 1 Diabetes or patients with diabetic ketoacidosis. Should not be used in patients with severe kidney impairment. Patients with liver disease or heart problems must consult their doctor before use. Avoid excessive alcohol intake as it increases the risk of lactic acidosis. Pregnant and breastfeeding women should only use it if prescribed by a healthcare professional. Stay hydrated to avoid dehydration from frequent urination caused by dapagliflozin. Drug Interactions GLIDAPAFLOZIN M 10/500 may interact with certain medicines, such as: Diuretics (water pills): May increase dehydration risk. Insulin or other antidiabetic drugs (sulfonylureas): May cause hypoglycemia. Drugs that affect kidney function (NSAIDs, ACE inhibitors): May increase side effects. Alcohol: Raises the risk of lactic acidosis when combined with metformin. Always inform your doctor about all medications and supplements you are taking. Conclusion GLIDAPAFLOZIN M 10/500 (Dapagliflozin and Metformin Hydrochloride Extended-Release) is a highly effective dual-therapy option for managing Type 2 Diabetes Mellitus. By combining the benefits of dapagliflozin and metformin, it not only helps control blood sugar levels but also supports weight management, reduces cardiovascular risks, and prevents long-term diabetes complications. For patients struggling with uncontrolled diabetes despite lifestyle changes or single-drug therapy, GLIDAPAFLOZIN M 10/500 offers a reliable solution. However, it should always be taken under proper medical supervision, with regular monitoring of blood sugar, kidney function, and overall health. Taking proactive steps with the right treatment like GLIDAPAFLOZIN M 10/500 can help patients live a healthier, more balanced life with better diabetes control.